Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.335
-0.095 (-3.91%)
Feb 13, 2026, 2:59 PM EST - Market open
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $214.54 million as of February 13, 2026. Its market cap has increased by 191.52% in one year.
Market Cap
214.54M
Enterprise Value
148.30M
1-Year Change
191.52%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $214.54M, an increase of 320.43%. That is a compound annual growth rate of 39.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 223.27M | 65.31% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 234.83M |
| Inhibikase Therapeutics | 233.90M |
| Nuvectis Pharma | 232.33M |
| Orchestra BioMed Holdings | 229.64M |
| Achieve Life Sciences | 227.84M |
| Opus Genetics | 226.89M |
| MediWound | 221.17M |
| Heron Therapeutics | 214.53M |